A New Jersey man has been named chief innovation officer for Zensights, a pharmaceutical vendor management firm, the company said this week.
In his new role, Dan Henry will lead the organization’s vision and execution of providing an outstanding user experience for Linx, the proprietary vendor analysis software tool that provides best-in-class insights on vendors supporting the pharma industry, the company said in a news release.
“Dan brings a wealth of digital expertise, specifically geared to the biopharmaceutical industry,” CEO Bob Jansen said in a statement. “With digital expertise at both the client level and also a transformational company like Outcome Health, Dan is well-qualified to lead the digital strategy for Zensights. Dan complements our existing senior leadership team and will be instrumental in the future product development of Linx.”
Henry, a resident of Spring Lake, will be based in New Jersey even though Zensights is based in Arizona, the company said. He has management and leadership experience with companies including GlaxoSmithKline and Otsuka America Pharmaceuticals.
